Liver X receptor (LXR) agonists have been reported to lower brain amyloid beta (Aβ) and thus to have potential for the treatment of Alzheimer's disease. Structure and property based design led to the discovery of a series of orally bioavailable, brain penetrant LXR agonists. Oral administration of compound 18 to rats resulted in significant upregulation of the expression of the LXR target gene ABCA1 in brain tissue, but no significant effect on Aβ levels was detected.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2016.08.089 | DOI Listing |
Publication Analysis
Top Keywords
brain penetrant
8
liver receptor
8
receptor lxr
8
lxr agonists
8
brain
4
penetrant liver
4
lxr
4
lxr modulators
4
modulators based
4
based 2456-tetrahydropyrrolo[34-c]pyrazole
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!